Erik Lueders is an expert in banking, strategy and financial services, M&A, investment management, and risk consulting. Dr. Lueders is an experienced financial sector executive with extensive experience in senior consulting roles. Working with leading financial institutions, technology, and logistics companies in Europe, the U.S., and emerging markets, he has consulted on a range of risk, innovation, consolidation, and regulatory issues. In addition, Dr. Lueders is a trained Ph.D. economist whose academic expertise includes financial mathematics and behavioral finance.
Dr. Lueders has been retained as an expert witness. He also has extensive experience engaging with regulatory agencies across multiple jurisdictions. Most of his interactions have been with European and German regulators, specifically the European Central Bank/Single Supervisory Mechanism (ECB/SSM); BaFin, Germany’s primary financial regulatory body; and the Deutsche Bundesbank. In addition, Dr. Lueders has worked with Asian financial regulators, including authorities in Singapore, Thailand, and Vietnam. His expertise includes work with a multilateral financial organization and work with the Swiss Antitrust Commission (WEKO) in the context of an attempted acquisition.
As a partner of SKR Beteiligungs AG, Dr. Lueders’s experience in M&A, corporate transactions, and private equity (PE) spans the full lifecycle—from deal origination and strategic business case development to due diligence, execution, and post-merger integration. He has worked across all transaction types, including mergers, corporate transformations, take-privates, and carve-outs. Dr. Lueders leads SKR’s due diligence activities, overseeing workstreams across financial, tax, legal, operational, and technological dimensions, as well as compliance and risk issues.
In addition, Dr. Lueders is a senior advisor in strategic risk management at Marsh, a leading global insurance broker and risk advisor. He serves on the supervisory board of mwb fairtrade Wertpapierhandelsbank AG, a listed financial services firm that manages securities, bonds, and investment funds.
Dr. Lueders served as a risk advisory partner at Deloitte, based in Frankfurt. In this role, he led risk advisory services for Deloitte’s Financial Services Industry (FSI) and Strategic and Reputation Risk (SRR) divisions in Germany. Managing a team of about 600 professionals, Dr. Lueders was responsible for approximately €100 million in revenues. He also served on Deloitte’s Innovation Board (iBoard), headed the firm’s Banking Union Center in Frankfurt (BUCF), and worked with European bank chief risk officers (CROs) as leader of Deloitte’s CRO Club.
Before joining Deloitte, Dr. Lueders was a partner at Ernst & Young in Germany, overseeing all risk, internal audit, and regulatory issues involving financial institutions. He also led the firm’s Strategic Risk practice for Europe, the Middle East, India, and Africa (EMEIA). Previously, at McKinsey & Company, Dr. Lueders co-led the German Risk Practice and the German Risk Analytics Group, consulting on capital and balance sheet management, liquidity and funding, banking regulation (Basel II/III), credit processes, strategy, and M&A. Prior to his time as a consultant, he worked for a PE firm in California.
Dr. Lueders has held academic appointments as a finance professor and researcher, including at Canada’s Laval University, New York University’s Stern School of Business, and the Centre for European Economic Research (ZEW) in Mannheim, Germany. In these capacities, he has taught and researched topics related to asset pricing, behavioral finance, and risk management.
Dr. Lueders has published articles in academic and specialist journals, including the Review of Finance, the Review of Derivatives Research, the Journal of Economic Behavior & Organization, and the Journal of Personal Finance. His research spans multiple finance and banking topics, with an emphasis on risk management; regulatory compliance, especially in the context of Basel III; capital management; option pricing models; and the impact of investor expectations on asset prices.